Paul Hartmann AG
F:PHH2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Paul Hartmann AG
F:PHH2
|
DE |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
Dividends
Dividend Yield
Paul Hartmann AG
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Paul Hartmann AG
PHH2 have increased by 7%.
Payout Ratio
Paul Hartmann AG
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
PHH2 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
PHH2 Price
Paul Hartmann AG
| Average Annual Return | -9.57% |
| Standard Deviation of Annual Returns | 17.5% |
| Max Drawdown | -49% |
| Market Capitalization | 713.9m EUR |
| Shares Outstanding | 3 570 000 |
| Percentage of Shares Shorted |
N/A
|
PHH2 Return Decomposition
Main factors of price return
Stock Splits
PHH2's latest stock split occurred on Sep 25, 2000
The company executed a 3-for-2 stock split, meaning that for every 2 shares held, investors received 3 new shares.
The adjusted shares began trading on Sep 25, 2000. This was the only stock split in PHH2's history.